glp-1 agonist anxiety side effects and Anxiety: What the Evidence Shows – Bolt Pharmacy Does Ozempic Cause Anxiety? Evidence
Description
doi: 10.2337/dc11-1928
The SURPASS-1 trial demonstrated significant improvements in glycemic control and substantial reductions in body weight with all three doses of tirzepatide (5 mg, 10 mg, or 15 mg) compared to placebo over a 40-week period
, , ,
Whether milk transfer characteristics change with prolonged use is unknown
